skip to main content
Idioma:
Resultados 1 2 3 4 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficient light emission from inorganic and organic semiconductor hybrid structures by energy-level tuning
Efficient light emission from inorganic and organic semiconductor hybrid structures by energy-level tuning
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficient light emission from inorganic and organic semiconductor hybrid structures by energy-level tuning

Schlesinger, R ; Bianchi, F ; Blumstengel, S ; Christodoulou, C ; Ovsyannikov, R ; Kobin, B ; Moudgil, K ; Barlow, S ; Hecht, S ; Marder, S R ; Henneberger, F ; Koch, N

Nature communications, 2015-04, Vol.6 (1), p.6754-6754, Article 6754 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition
Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition
Material Type:
Artigo 		Adicionar ao Meu Espaço

Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition

Kilian, S ; Asmal, L ; Chiliza, B ; Olivier, MR ; Phahladira, L ; Scheffler, F ; Seedat, S ; Marder, SR ; Green, MF ; Emsley, R

Psychological medicine, 2018-10, Vol.48 (13), p.2186-2193 [Periódico revisado por pares]

Cambridge, UK: Cambridge University Press

Texto completo disponível

Citações Citado por
3
Repurposing Drugs for Cognition in Schizophrenia
Repurposing Drugs for Cognition in Schizophrenia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Repurposing Drugs for Cognition in Schizophrenia

Yang, YS ; Marder, SR ; Green, MF

Clinical pharmacology and therapeutics, 2017-02, Vol.101 (2), p.191-193 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

Marder, Stephen R. ; McQuade, Robert D. ; Stock, Elyse ; Kaplita, Stephen ; Marcus, Ronald ; Safferman, Allan Z. ; Saha, Anutosh ; Ali, Mirza ; Iwamoto, Taro

Schizophrenia research, 2003-06, Vol.61 (2), p.123-136 [Periódico revisado por pares]

Amsterdam: Elsevier B.V

Texto completo disponível

Citações Citado por
5
Adsorption studies of a phosphonic acid on ITO: film coverage, purity, and induced electronic structure changes
Adsorption studies of a phosphonic acid on ITO: film coverage, purity, and induced electronic structure changes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adsorption studies of a phosphonic acid on ITO: film coverage, purity, and induced electronic structure changes

Paniagua, S A ; Li, E L ; Marder, S R

Phys. Chem. Chem. Phys, 2014-01, Vol.16 (7), p.2874-2881 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
6
The effects of novel antipsychotics on glucose and lipid levels
The effects of novel antipsychotics on glucose and lipid levels
Material Type:
Artigo 		Adicionar ao Meu Espaço

The effects of novel antipsychotics on glucose and lipid levels

WIRSHING, Donna A ; BOYD, Jennifer A ; MENG, Laura R ; BALLON, Jacob S ; MARDER, Stephen R ; WIRSHING, William C

The journal of clinical psychiatry, 2002-10, Vol.63 (10), p.856-865 [Periódico revisado por pares]

Memphis, TN: Physicians Postgraduate Press

Texto completo disponível

Citações Citado por
7
Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation
Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation

MARDER, Stephen R ; SORSABURU, Sebastian ; DUNAYEVICH, Eduardo ; KARAGIANIS, Jamie L ; DAWE, Ian C ; FALK, Deborah M ; DELLVA, Mary Anne ; CARLSON, Janice L ; CAVAZZONI, Patrizia A ; BAKER, Robert W

The journal of clinical psychiatry, 2010-04, Vol.71 (4), p.433-441 [Periódico revisado por pares]

Memphis, TN: Physicians Postgraduate Press

Texto completo disponível

Citações Citado por
8
Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients
Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients

Aravagiri, M ; Marder, S.R

Journal of pharmaceutical and biomedical analysis, 2001-09, Vol.26 (2), p.301-311 [Periódico revisado por pares]

Amsterdam: Elsevier B.V

Texto completo disponível

Citações Citado por
9
Schizophrenia, IX: Cognition in Schizophrenia-The MATRICS Initiative
Schizophrenia, IX: Cognition in Schizophrenia-The MATRICS Initiative
Material Type:
Artigo 		Adicionar ao Meu Espaço

Schizophrenia, IX: Cognition in Schizophrenia-The MATRICS Initiative

Marder, Stephen R ; Fenton, Wayne ; Youens, Kenneth

The American journal of psychiatry, 2004-01, Vol.161 (1), p.25-25 [Periódico revisado por pares]

United States: American Psychiatric Publishing

Texto completo disponível

Citações Citado por
10
Association of 9-Hydroxy Risperidone Concentrations With Risk of Switching or Discontinuation in the Clinical Antipsychotic Trial of Intervention Effectiveness-Alzheimer's Disease Trial
Association of 9-Hydroxy Risperidone Concentrations With Risk of Switching or Discontinuation in the Clinical Antipsychotic Trial of Intervention Effectiveness-Alzheimer's Disease Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of 9-Hydroxy Risperidone Concentrations With Risk of Switching or Discontinuation in the Clinical Antipsychotic Trial of Intervention Effectiveness-Alzheimer's Disease Trial

WESSELS, Alette M ; POLLOCK, Bruce G ; ANYAMA, Norbert G ; SCHNEIDER, Lon S ; LIEBERMAN, Jeffrey A ; MARDE, Stephen R ; BIES, Robert R

Journal of clinical psychopharmacology, 2010-12, Vol.30 (6), p.683-687 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (33)
  2. Revistas revisadas por pares (31)

Data de Publicação 

De até
Refinar
  1. Antes de1988  (6)
  2. 1988Até1996  (7)
  3. 1997Até2002  (8)
  4. 2003Até2014  (12)
  5. Após 2014  (5)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.